| |
| |
|
| Insider
Information: |
Kosaraju Sridhar |
| Relationship: |
|
| City: |
Alameda |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
141,699 |
|
|
Indirect Shares
|
158,351 |
|
|
| Direct
Value |
$14,418,992 |
|
|
|
Indirect Value
|
$30,512,490 |
|
|
| Total
Shares |
300,050 |
|
|
| Total
Value |
$44,931,482 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Penumbra Inc |
PEN |
President |
2019-04-29 |
71,601 |
2020-04-15 |
155,351 |
Premium* |
|
|
10x Genomics, Inc. |
TXG |
|
2023-06-14 |
32,443 |
2023-06-14 |
3,000 |
Premium* |
|
|
Nevro Corp |
NVRO |
|
2024-05-23 |
37,655 |
2021-08-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
70 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PEN |
Penumbra Inc |
CFO and Head of Strategy |
• – – |
2017-11-24 |
4 |
AS |
$103.51 |
$230,827 |
I/I |
(2,218) |
61,173 |
0 |
- |
|
| PEN |
Penumbra Inc |
CFO and Head of Strategy |
• – – |
2017-11-27 |
4 |
AS |
$103.45 |
$366,455 |
I/I |
(3,525) |
57,648 |
0 |
- |
|
| PEN |
Penumbra Inc |
CFO and Head of Strategy |
• – – |
2017-11-28 |
4 |
AS |
$103.20 |
$259,236 |
I/I |
(2,501) |
55,147 |
0 |
- |
|
| PEN |
Penumbra Inc |
CFO and Head of Strategy |
• – – |
2018-04-28 |
4 |
D |
$126.45 |
$10,066,937 |
D/D |
(79,612) |
222,819 |
0 |
- |
|
| PEN |
Penumbra Inc |
CFO and Head of Strategy |
• – – |
2019-03-11 |
4 |
AS |
$138.30 |
$699,220 |
I/I |
(5,000) |
120,750 |
0 |
- |
|
| PEN |
Penumbra Inc |
CFO and Head of Strategy |
• – – |
2019-04-01 |
4 |
AS |
$141.84 |
$717,251 |
I/I |
(5,000) |
115,750 |
0 |
- |
|
| PEN |
Penumbra Inc |
CFO and Head of Strategy |
• – – |
2019-04-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(79,615) |
71,601 |
0 |
- |
|
| PEN |
Penumbra Inc |
CFO and Head of Strategy |
• – – |
2019-05-01 |
4 |
AS |
$130.23 |
$72,678 |
I/I |
(551) |
186,800 |
0 |
- |
|
| PEN |
Penumbra Inc |
CFO and Head of Strategy |
• – – |
2019-05-02 |
4 |
AS |
$130.04 |
$578,548 |
I/I |
(4,449) |
182,351 |
0 |
- |
|
| PEN |
Penumbra Inc |
CFO and Head of Strategy |
• – – |
2019-05-17 |
4 |
GD |
$0.00 |
$0 |
I/I |
1,000 |
181,351 |
0 |
- |
|
| PEN |
Penumbra Inc |
CFO and Head of Strategy |
• – – |
2019-06-03 |
4 |
AS |
$140.73 |
$714,461 |
I/I |
(5,000) |
176,351 |
0 |
- |
|
| PEN |
Penumbra Inc |
CFO and Head of Strategy |
• – – |
2019-07-01 |
4 |
AS |
$159.54 |
$799,802 |
I/I |
(5,000) |
171,351 |
0 |
- |
|
| PEN |
Penumbra Inc |
CFO and Head of Strategy |
• – – |
2019-08-01 |
4 |
AS |
$166.78 |
$846,824 |
I/I |
(5,000) |
166,351 |
0 |
- |
|
| PEN |
Penumbra Inc |
CFO and Head of StrategyOffice |
• – – |
2015-09-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
539,607 |
|
- |
|
| TXG |
10x Genomics, Inc. |
Director |
– • – |
2019-09-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
10,833 |
|
- |
|
| TXG |
10x Genomics, Inc. |
Director |
– • – |
2019-09-16 |
4 |
A |
$0.00 |
$0 |
I/I |
10,833 |
10,833 |
0 |
- |
|
| TXG |
10x Genomics, Inc. |
Director |
– • – |
2019-09-16 |
4 |
D |
$0.00 |
$0 |
I/I |
(10,833) |
0 |
0 |
- |
|
| TXG |
10x Genomics, Inc. |
Director |
– • – |
2020-05-29 |
4 |
OE |
$11.48 |
$114,800 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| TXG |
10x Genomics, Inc. |
Director |
– • – |
2021-01-25 |
4 |
GA |
$0.00 |
$0 |
I/I |
7,167 |
18,000 |
0 |
- |
|
| TXG |
10x Genomics, Inc. |
Director |
– • – |
2021-01-25 |
4 |
GD |
$0.00 |
$0 |
D/D |
7,167 |
2,833 |
0 |
- |
|
| TXG |
10x Genomics, Inc. |
Director |
– • – |
2021-03-23 |
4 |
AS |
$173.96 |
$261,939 |
I/I |
(1,500) |
16,500 |
0 |
- |
|
| TXG |
10x Genomics, Inc. |
Director |
– • – |
2021-04-23 |
4 |
AS |
$190.05 |
$289,623 |
I/I |
(1,500) |
15,000 |
0 |
- |
|
| TXG |
10x Genomics, Inc. |
Director |
– • – |
2021-05-24 |
4 |
AS |
$160.05 |
$241,746 |
I/I |
(1,500) |
13,500 |
0 |
- |
|
| TXG |
10x Genomics, Inc. |
Director |
– • – |
2021-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
625 |
3,458 |
0 |
- |
|
| TXG |
10x Genomics, Inc. |
Director |
– • – |
2021-06-23 |
4 |
AS |
$197.26 |
$299,923 |
I/I |
(1,500) |
12,000 |
0 |
- |
|
70 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
